241 related articles for article (PubMed ID: 1617832)
1. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
2. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situ.
Lala PK; Elkashab M; Kerbel RS; Parhar RS
Int Immunol; 1990; 2(12):1149-58. PubMed ID: 2090199
[TBL] [Abstract][Full Text] [Related]
3. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
Lala PK; Parhar RS
Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
[TBL] [Abstract][Full Text] [Related]
4. Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.
Saarloos MN; Khoo NK; Lala PK
Clin Exp Metastasis; 1993 May; 11(3):275-83. PubMed ID: 8097142
[TBL] [Abstract][Full Text] [Related]
5. Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy.
Lala PK; Parhar RS
Int J Cancer; 1993 Jun; 54(4):677-84. PubMed ID: 8514459
[TBL] [Abstract][Full Text] [Related]
6. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
Saarloos MN; Khoo NK; Lala PK
Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.
Parhar RS; Lala PK
J Exp Med; 1987 Jan; 165(1):14-28. PubMed ID: 3491867
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production.
Timoshenko AV; Lan Y; Gabius HJ; Lala PK
Eur J Cancer; 2001 Oct; 37(15):1910-20. PubMed ID: 11576848
[TBL] [Abstract][Full Text] [Related]
11. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise.
Lala PK; Scodras JM; Graham CH; Lysiak JJ; Parhar RS
Cell Immunol; 1990 May; 127(2):368-81. PubMed ID: 2328531
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin-enhanced immunotherapy of pulmonary metastases using IL-2 and IFN-alpha.
Kim B; Warnaka P
Surgery; 1989 Aug; 106(2):248-55; discussion 255-6. PubMed ID: 2788316
[TBL] [Abstract][Full Text] [Related]
13. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Orucevic A; Lala PK
Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
[TBL] [Abstract][Full Text] [Related]
14. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
Jadeski LC; Hum KO; Chakraborty C; Lala PK
Int J Cancer; 2000 Apr; 86(1):30-9. PubMed ID: 10728591
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
[TBL] [Abstract][Full Text] [Related]
18. Cure of murine Ehrlich ascites tumors with chronic oral indomethacin therapy combined with intraperitoneal administration of LAK cells and IL-2.
Lala PK; Parhar RS; Singh P; Lala PK
Cancer Lett; 1990 May; 51(1):27-35. PubMed ID: 2337895
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
20. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
